首頁 > 市場調查報告書 > 製藥

疼痛

市場調查報告書

商品編碼

1619044

疼痛管理市場規模、佔有率、成長分析、按類型、按適應症、按購買模式、按最終用戶、按地區 - 行業預測，2024-2031 年

Pain Management Market Size, Share, Growth Analysis, By Types (Non-Steroidal Anti-Inflammatory Drugs, Anticonvulsants), By Indication, By Mode of Purchase, By End-User, By Region - Industry Forecast 2024-2031

出版日期: 2024年12月18日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球疼痛管理市場規模為752億美元，從2023年的784.3億美元成長到2031年的1098.4億美元，複合年成長率預計為4.3%。

由於關節炎、癌症疼痛和肌肉骨骼疾病等慢性疼痛疾病的盛行率不斷上升，全球疼痛管理市場正在強勁成長。慢性疼痛對日常生活有重大影響，增加了對有效止痛解決方案的需求。技術和治療方案的進步，包括新藥和微創手術，正在增強醫療保健專業人員有效管理疼痛的方法。然而，市場正面臨鴉片類藥物危機等挑戰，導致監管加強和轉向非鴉片類藥物替代品。此外，高昂的治療費用和不同的報銷政策也可能限制服務不足的人口的獲得服務。疼痛的主觀性質使個人化治療策略變得複雜，並且需要對每個患者的情況有細緻入微的了解。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東/非洲
- 海灣合作理事會國家
- 南非
- 其他中東/非洲

競爭資訊

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2023）
主要企業簡介
- 公司簡介
- 產品系列分析
- 按細分市場分類的佔有率分析
- 收益與前一年同期比較（2021-2023）

主要企業簡介

Teva Pharmaceutical
Pfizer
Abbott
Mallinckrodt Pharmaceuticals
Endo International
GlaxoSmithKline
AstraZeneca
Depomed
Merck
Novartis
Eli Lilly and Company
Genentech
Tonix Pharmaceuticals
NeuSpera Medical
Oculis
Aspen Laser
Hyperice
Orofacial Therapeutics Inc.
Pain Care Labs
Medtronic

結論和建議

簡介目錄

Product Code: SQMIG35I2271

Global Pain Management Market size was valued at USD 75.2 billion in 2022 and is poised to grow from USD 78.43 billion in 2023 to USD 109.84 billion by 2031, growing at a CAGR of 4.3% during the forecast period (2024-2031).

The global pain management market is experiencing robust growth, fueled by the rising prevalence of chronic pain conditions like arthritis, cancer pain, and musculoskeletal disorders. As chronic pain significantly impacts daily life, the demand for effective pain relief solutions is escalating. Advances in technology and treatment options, including novel pharmaceuticals and minimally invasive procedures, enhance the approach healthcare professionals can take to manage pain effectively. However, the market faces challenges such as the opioid crisis, leading to heightened regulations and a shift towards non-opioid alternatives. Additionally, high treatment costs and varying reimbursement policies can limit access for underserved populations. The subjective nature of pain complicates personalized treatment strategies, necessitating a nuanced understanding of each patient's situation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pain Management market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pain Management Market Segmental Analysis

Global Pain Management Market is segmented by types, indication, mode of purchase, end-user and region. Based on types, the market is segmented into non-steroidal anti-inflammatory drugs (NSAIDS), anticonvulsants, sedatives, narcotics, antimigraine specialists, antidepressants and others. Based on indication, the market is segmented into delegated neuropathic torment, disease torment, facial agony and headache, musculoskeletal torment, fibromyalgia, persistent back torment, joint torment, headache and post-usable torment. Based on mode of purchase, the market is segmented into over the counter and solution-based. Based on end-user, the market is segmented into emergency clinics and facilities, drug organizations, clinical gadget organizations, examination and educational establishments. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pain Management Market

The Global Pain Management market is significantly driven by a heightened awareness regarding the effects of pain on individuals' quality of life. As healthcare providers, patients, and policymakers increasingly recognize the importance of effective pain relief, there's a concerted effort aimed at enhancing research, education, and accessibility to pain management solutions. This growing commitment to patient-centric care coupled with the desire for improved outcomes in pain management is propelling the market forward. Emphasizing effective strategies for relieving pain not only benefits individuals but also fosters advancements in the overall healthcare landscape, further driving interest and investment in this vital sector.

Restraints in the Global Pain Management Market

The Global Pain Management market faces significant constraints due to the high expense associated with treatments. Advanced procedures, devices, and specialized therapies often come with steep price tags that can hinder market growth. This financial barrier particularly affects access for various patient populations, particularly in low-income areas or countries with constrained healthcare resources. Consequently, many individuals may be unable to afford necessary pain management interventions, which can result in untreated conditions and overall suboptimal health outcomes. As a result, the high cost of these treatments remains a critical factor slowing the expansion of the pain management market worldwide.

Market Trends of the Global Pain Management Market

The Global Pain Management market is experiencing a significant trend towards multimodal and individualized approaches, reflecting a shift in how pain is managed. This trend encompasses the integration of diverse therapies-ranging from pharmacological treatments and physical therapy to psychological interventions and lifestyle modifications-allowing for comprehensive care that addresses pain from multiple dimensions. As healthcare providers increasingly recognize the importance of tailoring pain management strategies to each patient's unique circumstances-including the nature of their pain, existing comorbidities, and personal preferences-this evolving paradigm is expected to enhance patient outcomes and drive substantial growth within the market through more effective, personalized treatment options.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Regulatory Landscape
Case Studies

Global Pain Management Market Size by Types & CAGR (2024-2031)

Market Overview
Non-Steroidal Anti-Inflammatory Drugs (Nsaids)
Anticonvulsants
Sedatives
Narcotics
Antimigraine Specialists
Antidepressants
Others

Global Pain Management Market Size by Indication & CAGR (2024-2031)

Market Overview
Delegated Neuropathic Torment
Disease Torment
Facial Agony and Headache
Musculoskeletal Torment
Fibromyalgia
Persistent Back Torment
Joint Torment
Headache
Post-Usable Torment

Global Pain Management Market Size by Mode Of Purchase & CAGR (2024-2031)

Market Overview
Over The Counter
Solution-Based

Global Pain Management Market Size by End-User & CAGR (2024-2031)

Market Overview
Emergency Clinics and Facilities
Drug Organizations
Clinical Gadget Organizations
Examination
Educational Establishments

Global Pain Management Market Size & CAGR (2024-2031)

North America (Types, Indication, Mode of Purchase, End-User)
- USA
- Canada
Europe (Types, Indication, Mode of Purchase, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Types, Indication, Mode of Purchase, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Types, Indication, Mode of Purchase, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Types, Indication, Mode of Purchase, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Teva Pharmaceutical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mallinckrodt Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endo International
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Depomed
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genentech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tonix Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NeuSpera Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oculis
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aspen Laser
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hyperice
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orofacial Therapeutics Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pain Care Labs
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments